MarketWatch Automation
Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA +0.84% advanced 6.41% to $282.35 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +1.01% rising 3.03% to 15,686.92 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.23% rising 1.40% to 35,719.43. Moderna Inc. closed $215.14 short of its 52-week high ($497.49), which the company reached on August 10th.
The stock outperformed some of its competitors Tuesday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +1.06% rose 0.13% to $121.51, Amgen Inc. /zigman2/quotes/209157011/composite AMGN +1.42% rose 1.21% to $211.32, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN +1.04% fell 1.17% to $54.76. Trading volume (10.8 M) remained 2.8 million below its 50-day average volume of 13.6 M.
Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.














